CCDC46 Activators
CCDC46 activators, primarily chemicals, intersect a plethora of cellular routes, revealing an expansive operational sphere wherein CCDC46 might function. For instance, Forskolin can enhance cAMP levels, offering a significant modulation impact on an array of cellular activities, some of which may overlay with CCDC46's actions. Chemicals such as MG132 and Epoxomicin inhibit the proteasome system, alluding to potential interactions with ubiquitin-proteasome pathways, possibly associated with CCDC46's role in the cell.
The list also incorporates inhibitors targeting the kinase realm, including U0126, PD98059, and SB203580, each of which zeroes in on pivotal nodes in the MAPK pathways. By regulating these routes, they can sculpt the cellular environment, and as a result, shape CCDC46-associated functions. The calcium modulators, Ionomycin and Thapsigargin, both play a critical role in determining calcium homeostasis and ER stress, respectively. Their actions spotlight the intricate cellular balance where minor adjustments can cascade to affect various proteins, inclusive of CCDC46's domain.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Elevates cAMP levels, affecting multiple cellular processes possibly associated with CCDC46 activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
A calcium ionophore that alters intracellular calcium levels, influencing cellular activities including CCDC46. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Induces ER stress, potentially influencing pathways or processes associated with CCDC46. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK; modulation of this pathway can impact cellular processes involving CCDC46. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor, potentially affecting pathways or cellular processes where CCDC46 operates. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor; affects various cellular processes and may indirectly influence CCDC46 functions. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor that might affect ubiquitin-proteasome processes possibly linked with CCDC46's function. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $134.00 $215.00 $440.00 $496.00 | 19 | |
Influences ubiquitin-proteasome systems, which can relate to CCDC46's operational context. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $99.00 $335.00 $836.00 $2099.00 | 47 | |
Impacts Notch signaling and can indirectly influence processes where CCDC46 is involved. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Targets p38 MAPK, offering potential modulation of cellular processes associated with CCDC46. | ||||||